We found that ErbB2 promotes survival of breast cancer cell detached from the ECM by a novel mechanism involving downregulation of transcription factor IRF6 and further downregulation of the cell death-promoting protein BLNK [23, 35]. Here, ERBB2 is linked to breast cancer.